Company intelligence / Profile preview

Neopenda

Chicago, Illinois, United Statesneopenda.com ↗

Ownership: Private
Employees: ~15
Development stage: Commercial

Overview

Neopenda’s flagship product neoGuard™ has been deployed across Kenya, Uganda, and Ghana with over 350 devices used and more than 35,000 hours of patient monitoring logged. The device has undergone clinical validation studies in the US and Uganda. It provides real-time vital sign data to clinicians for early intervention in neonatal distress. The company continues to expand its reach and adapt the technology for broader use cases including adults during the COVID‑19 pandemic.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceWearable deviceIoT-enabled medical device
Industry: Physiological Monitoring

Partnerships

Doctors Without Borders/MSFJoint Medical Stores UgandaAmericaresvarious NGOs/ministry partnerships under development

Beyond the preview

Go deeper on Neopenda.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neopenda.

Explore the full profile